16-29813701-C-G

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_145239.3(PRRT2):​c.647C>G​(p.Pro216Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,582,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P216H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00016 ( 0 hom. )

Consequence

PRRT2
NM_145239.3 missense

Scores

2
8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4O:1

Conservation

PhyloP100: 2.28

Publications

25 publications found
Variant links:
Genes affected
PRRT2 (HGNC:30500): (proline rich transmembrane protein 2) This gene encodes a transmembrane protein containing a proline-rich domain in its N-terminal half. Studies in mice suggest that it is predominantly expressed in brain and spinal cord in embryonic and postnatal stages. Mutations in this gene are associated with episodic kinesigenic dyskinesia-1. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
MVP-DT (HGNC:56029): (MVP divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.23823166).
BP6
Variant 16-29813701-C-G is Benign according to our data. Variant chr16-29813701-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 65757.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRRT2NM_145239.3 linkc.647C>G p.Pro216Arg missense_variant Exon 2 of 4 ENST00000358758.12 NP_660282.2 Q7Z6L0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRRT2ENST00000358758.12 linkc.647C>G p.Pro216Arg missense_variant Exon 2 of 4 1 NM_145239.3 ENSP00000351608.7 Q7Z6L0-1
ENSG00000280893ENST00000609618.2 linkn.647C>G non_coding_transcript_exon_variant Exon 2 of 6 5 ENSP00000476774.2 A0A0G2JLL6

Frequencies

GnomAD3 genomes
AF:
0.0000987
AC:
15
AN:
151936
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000152
AC:
33
AN:
217286
AF XY:
0.000144
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000576
Gnomad FIN exome
AF:
0.000101
Gnomad NFE exome
AF:
0.000165
Gnomad OTH exome
AF:
0.000386
GnomAD4 exome
AF:
0.000159
AC:
228
AN:
1430302
Hom.:
0
Cov.:
36
AF XY:
0.000158
AC XY:
112
AN XY:
709432
show subpopulations
African (AFR)
AF:
0.0000619
AC:
2
AN:
32310
American (AMR)
AF:
0.000293
AC:
12
AN:
40928
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24004
East Asian (EAS)
AF:
0.0000511
AC:
2
AN:
39174
South Asian (SAS)
AF:
0.000146
AC:
12
AN:
81992
European-Finnish (FIN)
AF:
0.0000578
AC:
3
AN:
51922
Middle Eastern (MID)
AF:
0.000178
AC:
1
AN:
5612
European-Non Finnish (NFE)
AF:
0.000173
AC:
189
AN:
1095536
Other (OTH)
AF:
0.000119
AC:
7
AN:
58824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.602
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000987
AC:
15
AN:
151936
Hom.:
0
Cov.:
31
AF XY:
0.0000809
AC XY:
6
AN XY:
74198
show subpopulations
African (AFR)
AF:
0.0000725
AC:
3
AN:
41378
American (AMR)
AF:
0.0000655
AC:
1
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
67958
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000123
Hom.:
0
Bravo
AF:
0.000140
ExAC
AF:
0.0000992
AC:
12

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Episodic kinesigenic dyskinesia 1 Benign:1Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Nov 04, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PRRT2 c.647C>G (p.Pro216Arg) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00015 in 217286 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in PRRT2 causing Episodic Kinesigenic Dyskinesia 1, allowing no conclusion about variant significance. c.647C>G has been reported in the literature in individuals affected with Episodic Kinesigenic Dyskinesia, without strong evidence for causality (Liu _2013). These report(s) do not provide unequivocal conclusions about association of the variant with Episodic Kinesigenic Dyskinesia 1. Co-occurrences with other pathogenic variant(s) have been reported (PRRT2 c.510dup, p.Leu171SerfsX3), providing supporting evidence for a benign role (Liu _2013). At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant (Zhao_2019). ClinVar contains an entry for this variant (Variation ID: 65757). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Infantile convulsions and choreoathetosis Uncertain:1
Mar 01, 2019
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Episodic kinesigenic dyskinesia Benign:1
Oct 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Feb 29, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Mar 27, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20301633, 25502464, 23190448, 26598493, 31124310, 31154286) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Uncertain
0.062
T
BayesDel_noAF
Pathogenic
0.15
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.029
T;.;.;.;.;T;.;T;T
Eigen
Uncertain
0.22
Eigen_PC
Benign
0.18
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.76
.;.;T;T;T;.;T;.;T
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.24
T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.45
D
MutationAssessor
Benign
0.90
L;L;L;.;L;L;.;L;L
PhyloP100
2.3
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
0.47
N;.;N;.;N;.;.;.;.
REVEL
Uncertain
0.37
Sift
Pathogenic
0.0
D;.;D;.;D;.;.;.;.
Sift4G
Benign
0.10
T;.;T;.;T;.;.;T;.
Polyphen
0.99
D;D;D;.;D;D;.;D;D
Vest4
0.33
MVP
0.98
MPC
0.89
ClinPred
0.12
T
GERP RS
3.9
Varity_R
0.26
gMVP
0.34
Mutation Taster
=13/87
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76335820; hg19: chr16-29825022; API